Discover 1,760 paid clinical trials in Ann Arbor, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,760
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Ann Arbor MI, Detroit MI, Columbus OH, Chicago IL,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06635785
Phase 1, Phase 2, Recruiting
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
for
Prostate Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: Male
Age: 18+
Code: NCT05038332
Phase 2, Recruiting
Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Ann Arbor MI, Louisville KY, Philadelphia PA,
Sponsor: OncoC4, Inc.
Sex: All
Age: 18+
Code: NCT06352359
Phase 1, Recruiting
Prehabilitation Program to Improve Cardiac Reserve in High-Risk Patients Undergoing Hematopoietic Stem Cell Transplantation
for
Hematopoietic Stem Cell Transplant
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT05945121
Recruiting
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 3+
Code: NCT05866302
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT05901519
Phase 2, Recruiting
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
for
Breast Atypical Ductal Hyperplasia,
Location: Ann Arbor MI, Cleveland OH, Chicago IL, St Louis MO,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18 - 55
Code: NCT06184750
Phase 2, Recruiting
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma
Location: Ann Arbor MI, St Louis MO, Baltimore MD, New York NY,
Sponsor: Tvardi Therapeutics, Incorporated
Sex: All
Age: 18+
Code: NCT05440708
Phase 1, Phase 2, Recruiting
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
for
AL Amyloidosis
Location: Ann Arbor MI, Novi MI, West Bloomfield MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06022939
Phase 3, Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
for
Metastatic Colorectal Carcinoma,
Location: Ann Arbor MI, Grand Rapids MI, Columbus OH,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT05863195
Phase 3, Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06498635
Phase 3, Recruiting
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
for
Breast Cancer, Metastatic Gastric Cancer, Esophageal Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: Female
Age: 18+
Code: NCT05183126
Recruiting
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Location: Ann Arbor MI, Nashville TN, New York NY, Boston MA,
Sponsor: Remix Therapeutics
Sex: All
Age: 18+
Code: NCT06118086
Phase 1, Phase 2, Recruiting
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
for
Oropharyngeal Cancer
Location: Ann Arbor MI, Brighton MI, Detroit MI, Cleveland OH,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT05451004
Phase 3, Recruiting
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
for
Prostate Cancer
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: Male
Age: 40 - 70+
Code: NCT05965180
Recruiting
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Ann Arbor MI, Columbus OH, Chicago IL, Pittsburgh PA,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase 3, Recruiting
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Ann Arbor MI, Detroit MI, Toronto, Denver CO,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT06253130
Phase 1, Phase 2, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Ann Arbor MI, Detroit MI, Grand Rapids MI, Cleveland OH,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
for
Advanced Extrapulmonary Neuroendocrine Carcinoma,
Location: Ann Arbor MI, Ypsilanti MI, Canton MI, Chelsea MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05058651
Phase 2, Phase 3, Recruiting
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Ann Arbor MI, Detroit MI, Avon OH, Cleveland OH,